71 related articles for article (PubMed ID: 24412296)
1. Long-term complete response to intrathecal trastuzumab in a patient with leptomeningeal carcinomatosis due to her2- overexpressing breast cancer: Case report.
García FJV; Carrión NP; de la Cruz-Merino L
Medicine (Baltimore); 2020 Jan; 99(1):e18298. PubMed ID: 31895768
[TBL] [Abstract][Full Text] [Related]
2. Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer.
Fumet JD; Wickre M; Jacquot JP; Bizollon MH; Melis A; Vanoli A; Viel E
BMC Cancer; 2018 Aug; 18(1):839. PubMed ID: 30126360
[TBL] [Abstract][Full Text] [Related]
3. HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen.
Wu SA; Jia DT; Schwartz M; Mulcahy M; Guo K; Tate MC; Sachdev S; Kostelecky N; Escobar DJ; Brat DJ; Heimberger AB; Lukas RV
CNS Oncol; 2023 Sep; 12(3):CNS99. PubMed ID: 37219390
[TBL] [Abstract][Full Text] [Related]
4. Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy.
Schneider M; Wispel C; Potthoff AL; Heimann M; Borger V; Schaub C; Herrlinger U; Vatter H; Schuss P; Schäfer N
Curr Oncol; 2024 Apr; 31(5):2410-2419. PubMed ID: 38785461
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal carcinomatosis from gastric cancer successfully treated by the intrathecal methotrexate plus temozolomide and simultaneous radiotherapy: Case report and literatures review.
Liu Y
Cancer Biol Ther; 2017 Oct; 18(10):761-764. PubMed ID: 28881161
[TBL] [Abstract][Full Text] [Related]
6. Role of intrathecal chemotherapy in the management of meningeal carcinomatosis in patients with breast cancer.
Meneguetti RT; Cruz FJSM; Del Giglio A
Einstein (Sao Paulo); 2023; 21():eAO0481. PubMed ID: 38126659
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for leptomeningeal disease in breast cancer.
Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
[TBL] [Abstract][Full Text] [Related]
8. New strategies for the treatment of breast cancer with leptomeningeal metastasis.
Chew SM; Seidman AD
Curr Opin Oncol; 2023 Nov; 35(6):500-506. PubMed ID: 37820086
[TBL] [Abstract][Full Text] [Related]
9. Fatal progression of the leptomeningeal carcinomatosis from primary rectal adenocarcinoma: A case report.
Lee TG; Hwang HJ
Asian J Surg; 2024 May; 47(5):2328-2330. PubMed ID: 38336490
[No Abstract] [Full Text] [Related]
10. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?
Bardhan M; Dey D; Suresh V; Javed B; Venur VA; Joe N; Kalidindi R; Ozair A; Khan M; Mahtani R; Lo S; Odia Y; Ahluwalia MS
Expert Rev Neurother; 2024; 24(1):77-103. PubMed ID: 38145503
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal trastuzumab: What else do we need to consider?
Gao T; Zhang S; Li M
Neuro Oncol; 2023 Feb; 25(2):418-419. PubMed ID: 36534954
[No Abstract] [Full Text] [Related]
12. Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Glitza Oliva IC; Ferguson SD; Bassett R; Foster AP; John I; Hennegan TD; Rohlfs M; Richard J; Iqbal M; Dett T; Lacey C; Jackson N; Rodgers T; Phillips S; Duncan S; Haydu L; Lin R; Amaria RN; Wong MK; Diab A; Yee C; Patel SP; McQuade JL; Fischer GM; McCutcheon IE; O'Brien BJ; Tummala S; Debnam M; Guha-Thakurta N; Wargo JA; Carapeto FCL; Hudgens CW; Huse JT; Tetzlaff MT; Burton EM; Tawbi HA; Davies MA
Nat Med; 2024 Apr; ():. PubMed ID: 38649781
[No Abstract] [Full Text] [Related]
13. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
14. Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series.
Chahal J; Stopeck A; Clarke K; Livingston RB; Chalasani P
Neurol Sci; 2015 Sep; 36(9):1691-3. PubMed ID: 25990104
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis.
Chen IC; Lin CH; Jan IS; Cheng AL; Lu YS
J Formos Med Assoc; 2016 Apr; 115(4):243-8. PubMed ID: 25890495
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.
Smalley I; Law V; Wyatt C; Evernden B; Fang B; Koomen JM; Welsh EA; Macaulay RJB; Forsyth PA; Smalley KSM
Clin Cancer Res; 2020 May; 26(9):2163-2175. PubMed ID: 31924735
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports.
Meissner M; Addeo A
Case Rep Oncol; 2016; 9(3):586-592. PubMed ID: 27920689
[TBL] [Abstract][Full Text] [Related]
18. Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.
Smalley KS; Fedorenko IV; Kenchappa RS; Sahebjam S; Forsyth PA
Int J Cancer; 2016 Sep; 139(6):1195-201. PubMed ID: 27084046
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
Salgia S; Fleming GF; Lukas RV
J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
